A recent video hosted by Steve Kirsch, founder of the Vaccine Safety Research Foundation, along with experts Kevin McKernan, Dr. Byram Bridle, and Chris Martenson, shed light on concerning findings regarding Pfizer’s COVID-19 vaccines.
McKernan’s extensive testing, corroborated by multiple labs, uncovered bacterial plasmid DNA contamination in both Pfizer and Moderna’s COVID-19 mRNA vaccines. This contamination, originating from the manufacturing process, includes remnants of DNA plasmids from E. coli bacteria used to create the spike protein mRNA. Despite efforts to remove it, traces persist, potentially leading to unintended immune reactions.
Additionally, McKernan identified other contaminants, such as dsRNA (double-stranded RNA), which the immune system interprets as a sign of viral infection, triggering inflammation. The presence of foreign proteins, including those coding for antibiotic resistance or replication, further raised concerns.
One of the most alarming revelations is the deliberate concealment of the SV40 promoter, a sequence known to induce various cancers in laboratory animals. This information was not disclosed to regulatory bodies, posing a potential risk to those receiving the vaccine.
McKernan raised the possibility that the vaccine’s DNA contamination could be transmitted from a pregnant mother to her fetus. Communication between the mother and child in utero is a known phenomenon, and the presence of LNPs (lipid nanoparticles) may facilitate this exchange.
Furthermore, a mysterious stretch of RNA over 1,200 amino acids long was discovered in the vaccines, the purpose of which remains unknown. This discovery raises significant questions about the vaccine’s composition and potential implications for recipients.
Evidence strongly suggests that Pfizer intentionally concealed the SV40 promoter from regulators. Pfizer’s omission of this crucial information from visual and written descriptions, while including it in raw DNA sequence data submitted to regulators, indicates a deliberate effort to hide a contamination issue with foreseeable risks.
The expert panel emphasized that this selective annotation is clear evidence of intentional concealment, not a mere oversight. The fact that regulators have not held Pfizer accountable for this deception is a cause for concern.
The panelists also discussed the flaws in adverse event monitoring and the reporting of clinical trial data, highlighting Pfizer’s failure to report higher rates of cardiac death in the vaccine group. This lack of transparency erodes public trust and contributes to vaccine hesitancy.
In conclusion, the panelists urged regulatory agencies to conduct thorough and impartial investigations into these troubling findings. The onus is on these agencies to restore public confidence and ensure the safety and transparency of COVID-19 vaccines.